ESM1 and gastric cancer: To further elucidate the oncogenic functions of ESM1 in GC, we initially assessed endogenous levels of ESM1 in a panel of GC cell lines, including poorly differentiated (AGS, KATO-III, and MKN-45) and well-differentiated (N87) cells, using Western blotting.